NO ATC L01CE01 · updated 2 Nov 2026
Topotecan shortage in Norway
Is there a Topotecan shortage in Norway?
Yes. As of 2 Nov 2026, 3 Topotecan products are reported short in Norway, the first since 8 Jun 2026. The company estimate for the return is 31 Dec 2026 (latest 31 Mar 2027). Main reason: commercial decision or withdrawal.
Also short in Canada, Italy, Spain, Belgium. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Topotecan Ebewe 1 mg/ml konsentrat til infusjonsvæske, oppløsning, 4 ml hetteglass | EBEWE Pharma Ges.m.b.H Nfg. KG | 8 Jun 2026 | 31 Dec 2026 | Increased demand Uventet økt etterspørsel |
| NO | Hycamtin 0,25 mg kapsel, hard, 10 x 1 stk endoseblisterpakning | Sandoz Pharmaceuticals d.d. | 28 Sep 2026 | 31 Mar 2027 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Hycamtin 1 mg kapsel, hard, 10 x 1 stk endoseblisterpakning | Sandoz Pharmaceuticals d.d. | 28 Sep 2026 | 31 Mar 2027 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).